Compound News and Research

RSS

Early Phase II clinical trial for RK-023 to treat androgenetic alopecia

R-Tech Ueno, Ltd. has started early Phase II clinical trial for RK-023, a physiologically active fatty acid derivative developed by the company -- a new compound targeted as a treatment for androgenetic alopecia (male pattern baldness).

7 Oct 2009

NIMH awards SRI International a $6.3M contract for study of ligands for brain imaging research

SRI International, an independent nonprofit research and development organization, announced today that it has been awarded a $6.3 million contract by the National Institute of Mental Health (NIMH) to conduct preclinical safety studies of promising novel ligands that will be used for brain imaging research and clinical applications.

6 Oct 2009

Grifols International chosen as Health Robotics' exclusive CytoCare partner in Latin America

Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Grifols International S.A. for its revolutionary CytoCare Robot.

6 Oct 2009

Kevetrin reduces tumor volume by 72%: Cellceutix

October is breast cancer awareness month with many supporters touting pink ribbons, but in health stocks investors are watching the market closely for news of new drugs in various stages of testing. Recently, Cellceutix announced its pharmaceutical compound Kevetrin reduced tumor volume by 72%, giving new hope for breast cancer patients.

6 Oct 2009

YM BioSciences to acquire Cytopia

Cytopia Limited has today announced that Cytopia and Toronto-based YM BioSciences Inc. ("YM") have signed an exclusive and binding Implementation Agreement ("Agreement") in which it is proposed that YM will acquire all of the issued shares and options in Cytopia.

6 Oct 2009

Global retail market for probiotic foods and beverages shows 13 percent increase over 2007

Once relegated primarily to the domain of yogurt and high-fiber fare, the market for food and beverage products fortified with probiotics and prebiotics has taken off as digestive health emerged as one of the hottest topics in the food and beverage arena.

5 Oct 2009

Researchers examine effects of curcumin on HNSCC growths

Curcumin, the compound that gives curry powder its yellow/orange color, may inhibit the adverse effects of nicotine in patients with head and neck cancer who continue to smoke.

4 Oct 2009

Bristol-Myers Squibb to present new data on BARACLUDE and other compounds at the AASLD 2009

New data on four Bristol-Myers Squibb Company (NYSE:BMY) compounds will be presented at the 60th annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston from October 30 to November 3.

3 Oct 2009

Publix Pharmacies offers to compound Tamiflu into an oral suspension for no additional charge

In response to the shortage of Tamiflu in liquid form, all 795 Publix Pharmacies will offer to compound Tamiflu into an oral suspension.

3 Oct 2009

CSPI sues Bayer for false claims on Men's One A Day multivitamins

The Center for Science in the Public Interest has sued the German drug company Bayer for falsely claiming that the selenium in Men's One A Day multivitamins might reduce the risk of prostate cancer. The lawsuit is filed in the Superior Court of California in San Francisco.

3 Oct 2009

UNICEF: Number of children affected by natural disasters growing

UN children's agency UNICEF is appealing for immediate assistance to help meet the growing needs of children and families in south Asia and the Pacific affected by the recent spate of natural disasters that have devastated a number of countries in these regions.

3 Oct 2009

Health Enhancement Products, Changing Times Vitamins terminate their current distribution agreement

Health Enhancement Products, Inc. and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).

3 Oct 2009

Dapagliflozin with metformin reduces glycosylated hemoglobin level and body weight

Results from a 24-week phase 3 clinical study demonstrated that the investigational drug dapagliflozin, added to metformin, demonstrated significant mean reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c) and in the secondary endpoint, fasting plasma glucose (FPG) in patients with type 2 diabetes inadequately controlled with metformin alone, as compared to placebo plus metformin.

3 Oct 2009

Molecular mechanisms of BN108 and timosaponin AIII described in a journal

Bionovo, Inc. today announced the publication in the peer-reviewed, open-access journal Public Library of Science One (PLoS ONE) of a paper describing the molecular mechanisms underlying the selective cytotoxic activity of its drug candidate BN108 and its active compound, timosaponin AIII.

2 Oct 2009

sNDA for Clonicel submitted to the FDA

Addrenex Pharmaceuticals and Sciele Pharma, Inc., a Shionogi company today announced that Addrenex has submitted a supplemental New Drug Application (sNDA) to the United States Food and Drug Administration (FDA) for Clonicel (modified-release clonidine) to treat attention deficit hyperactivity disorder (ADHD).

2 Oct 2009

Merrimack and sanofi-aventis collaborate to develop and co-commercialize MM-121, a monoclonal antibody

Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today the signing of an exclusive worldwide licensing agreement for the development and co-commercialization of MM-121, a first-in-class, fully human monoclonal antibody designed to block signaling of the ErbB3 receptor. MM-121 is currently in Phase 1 clinical testing.

1 Oct 2009

Study shows students do not follow proper hygiene routines

Thousands of bacteria lurk in college dormitories, but students are not following proper hygiene routines to help protect themselves from serious illness, according to a study released today from the Simmons College Center for Hygiene and Health in Home and Community, sponsored by an educational grant from LYSOL® brand products.

1 Oct 2009

Asia Pacific spinal nonfusion market to increase at compound annual growth rate by 2013

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the spinal nonfusion market will increase at a compound annual growth rate of almost 17% through 2013.

1 Oct 2009

Trichodesmium has important role in nitrogen cycle and carbon sequestration

A new study of microscopic marine microbes, called phytoplankton, by researchers at Woods Hole Oceanographic Institution (WHOI) and the University of South Carolina has solved a ten-year-old mystery about the source of an essential nutrient in the ocean.

1 Oct 2009

Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate

Emergent BioSolutions Inc. announced today that it was awarded a cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to further the development of one of Emergent’s advanced anthrax vaccine candidates known as dmPA7909.

30 Sep 2009

Compound News and Research

Early Phase II clinical trial for RK-023 to treat androgenetic alopecia

NIMH awards SRI International a $6.3M contract for study of ligands for brain imaging research

Grifols International chosen as Health Robotics' exclusive CytoCare partner in Latin America

Kevetrin reduces tumor volume by 72%: Cellceutix

YM BioSciences to acquire Cytopia

Global retail market for probiotic foods and beverages shows 13 percent increase over 2007

Researchers examine effects of curcumin on HNSCC growths

Bristol-Myers Squibb to present new data on BARACLUDE and other compounds at the AASLD 2009

Publix Pharmacies offers to compound Tamiflu into an oral suspension for no additional charge

CSPI sues Bayer for false claims on Men's One A Day multivitamins

UNICEF: Number of children affected by natural disasters growing

Health Enhancement Products, Changing Times Vitamins terminate their current distribution agreement

Dapagliflozin with metformin reduces glycosylated hemoglobin level and body weight

Molecular mechanisms of BN108 and timosaponin AIII described in a journal

sNDA for Clonicel submitted to the FDA

Merrimack and sanofi-aventis collaborate to develop and co-commercialize MM-121, a monoclonal antibody

Study shows students do not follow proper hygiene routines

Asia Pacific spinal nonfusion market to increase at compound annual growth rate by 2013

Trichodesmium has important role in nitrogen cycle and carbon sequestration

Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate

Advancing therapeutic biopolymer development eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News